Male breast cancer: Is the incidence increasing?

Annals of Surgical Oncology

Volumn 11, Issue 8, 2004, Pages 751-755

  Hodgson, Nicole C F ^a,c   Button, Jaclyn H ^b   Franceschi, Dido ^a   Moffat, Frederick L ^a   Livingstone, Alan S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Florida Cancer Data System   (United States)

^c Division of Surgical Oncology   (United States)

Author keywords

Epidemiology; Incidence; Male breast cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CONFIDENCE INTERVAL; DATA ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; METASTASIS; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; SCHOOL CHILD; TIME SERIES ANALYSIS; UNITED STATES; BREAST TUMOR; CANCER REGISTRY; INCIDENCE; MIDDLE AGED; REGISTER; REGRESSION ANALYSIS; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; FLORIDA; HUMANS; INCIDENCE; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; MIDDLE AGED; REGISTRIES; SEER PROGRAM;

EID: 6944231271     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.01.001     Document Type: Article

References (14)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2000 Incidence. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, 2003.
2. Donegan WI, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 2000;89:561-73.
3. Joshi MG, Lee Ak, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996;77:490-8.
4. Gough DB, Donohue JH, Evans MM, et al. A 50 year experience of male breast cancer; is outcome changing? Surg Oncol 1993;2:325-33.
5. Guinee VF, Olsson H, Moller T, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 1993;71:154-61.
6. National Cancer Institute. Surveillance, Epidemiology and End Results Program. Available at http://www.seer.cancer.gov. Accessed: April, 2004.
7. O'Malley C, Prehn A, Shema S, Glaser S. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer 2002;94:2836-43.
8. Percy C, van Holten V, Muir C. International classification of diseases for oncology. Geneva: World Health Organization, 1990.
9. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods. 2nd ed. Boston: PWS Kent Publishing Co, 1988.
10. Kiatkowska E, Teresiak M, Filas V, et al. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 2003;9:4452-9.
11. Leibowitz SB, Garber JE, Fox EA, et al. Male patients with diagnoses of both breast cancer and prostate cancer. Breast J 2003;9:208-12.
12. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 2003;127:36-41.
13. Johnson KC, Pan S, Mao Y. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev 2002;11:253-63.
14. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 1995;375:581-5.